Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metoclopramide-ceruletide assisted small bowel examination.

K Grumbach1, H Herlinger, I Laufer

  • 1Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia 19104.

Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|July 1, 1988
PubMed
Summary

This study tested whether combining metoclopramide and ceruletide could improve imaging of the small bowel. Three groups of patients were compared: one receiving both drugs, one receiving only metoclopramide, and one with no drugs. The combined group had the shortest exam time at 29.3 minutes. In about half of these patients, individual bowel loops were clearly visible under fluoroscopy. The unaided group took over an hour. The authors suggest that this combination may improve diagnostic access and reduce time. They propose that this could be a valuable addition to standard imaging protocols.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimal clinically important differences in the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0) in patients with symptomatic spinal metastases.

The spine journal : official journal of the North American Spine Society·2026
Same author

Erratum: Addressing the challenges of conducting community-engaged research during COVID-19: Rapid development and evaluation of a COVID-19 Research Patient and Community Advisory Board (PCAB) - CORRIGENDUM.

Journal of clinical and translational science·2025
Same author

A novel electroencephalography-based tool for objective assessment of network dynamics activated by nociceptive stimuli.

European journal of pain (London, England)·2015
Same author

Cement salvage of instrumentation-associated vertebral fractures.

AJNR. American journal of neuroradiology·2014
Same author

Network dynamics predict improvement in working memory performance following donepezil administration in healthy young adults.

NeuroImage·2013
Same author

Radiography Versus Colonoscopy in Evaluation of Colonic IBD.

Inflammatory bowel diseases·2013

Area of Science:

  • Gastrointestinal imaging techniques
  • Pharmacological enhancement in radiology
  • Diagnostic radiology procedures

Background:

Standard upper gastrointestinal and small bowel imaging often requires extended time and limited visualization. Prior research has shown that unaided examinations can take over an hour to complete. Delays in transit limit diagnostic clarity in the small bowel. It was already known that metoclopramide alone can reduce examination time. However, no prior work had resolved how to further optimize this process. This gap motivated investigation into additional pharmacological assistance. The goal was to determine if combining agents could improve both speed and image quality. No prior study had directly compared this combined approach to standard methods.

Purpose Of The Study:

This study aimed to assess whether combining metoclopramide with ceruletide could enhance small bowel imaging. The specific problem was slow transit and poor visualization in standard procedures. Researchers sought to determine if this combination could reduce examination time. They also wanted to evaluate whether it improved diagnostic access to bowel loops. The motivation stemmed from the need for faster, clearer imaging. No prior work had tested this dual-agent approach in this context. The authors proposed that this combination might improve both efficiency and diagnostic yield. This study tested that hypothesis in a controlled setting.

Keywords:
pharmacological enhancementfluoroscopic imagingsmall bowel transitgastrointestinal radiology

Frequently Asked Questions

The combination may produce contracted fold patterns in the jejunum and ileum, allowing better fluoroscopic access to individual loops in about 50% of subjects.

Ceruletide is injected to hasten small bowel transit and may help create contracted fold patterns that improve diagnostic access.

Fluoroscopy allows real-time imaging of bowel loops and is used to assess the accessibility of individual segments under the effects of the drugs.

Approximately half of the subjects in the combined drug group had individual bowel loops accessible for study under fluoroscopy.

Related Experiment Videos

Main Methods:

Three groups of patients were compared in this clinical trial. Group I received metoclopramide and ceruletide during imaging. Group II received metoclopramide alone. Group III had no pharmacological assistance. Fluoroscopic imaging tracked transit times and visualization quality. Duration of the entire examination was recorded for each group. The number of accessible bowel loops was also measured. No additional imaging tools were used beyond standard fluoroscopy. The primary outcome was the time required to complete the study.

Main Results:

Group I had an average examination duration of 29.3 minutes. Group II averaged 37.6 minutes, and Group III averaged 69.1 minutes. The combined agents reduced time by nearly 58% compared to unaided exams. In 50% of Group I patients, individual bowel loops were clearly visible. Metoclopramide alone reduced time by 43% compared to unaided exams. Ceruletide injection produced contracted fold patterns in the small intestine. These patterns allowed better fluoroscopic access to bowel segments. The combination improved diagnostic access without increasing complications.

Conclusions:

The authors suggest that combining metoclopramide with ceruletide may improve small bowel imaging. They propose that this approach could reduce examination duration significantly. The contracted fold patterns observed may enhance diagnostic clarity. This method may allow better visualization of individual bowel loops. The findings suggest that this combination could be more efficient than metoclopramide alone. No prior work had demonstrated this specific effect of ceruletide in this context. The results may support further investigation into this technique. The authors suggest that this could be a valuable addition to standard imaging protocols.

The mean duration for the combined drug group was 29.3 minutes, compared to 37.6 minutes for metoclopramide alone and 69.1 minutes for unaided exams.

The authors suggest that this combination may improve diagnostic access and reduce examination time, potentially supporting further investigation into this technique.